| Trait Information | |
| Identifier | MONDO_0005515 |
| Description | A primary or metastatic malignant neoplasm involving the oral cavity. The majority are squamous cell carcinomas. [NCIT: C9314] | Trait category |
Other trait
|
| Synonyms |
27 synonyms
|
| Child trait(s) | tongue cancer |
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS000081 (CC_Oral) |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Oral cavity and pharyngeal cancers | oral cavity cancer, pharynx cancer |
14 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000081/ScoringFiles/PGS000081.txt.gz |
| PGS000357 (PRSWEB_PHECODE145_C3-LIP-ORAL-PHARYNX_PT_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Oral cavity cancer | oral cavity cancer | 45 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000357/ScoringFiles/PGS000357.txt.gz | |
| PGS000358 (PRSWEB_PHECODE145_UKBB-SAIGE-HRC-X145_PRS-CS_MGI_20200608) |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Oral cavity cancer | oral cavity cancer | 1,119,238 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000358/ScoringFiles/PGS000358.txt.gz | |
| PGS000792 (CC_Oral_IV) |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Oral cavity and pharyngeal cancers | oral cavity cancer, pharynx cancer |
14 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000792/ScoringFiles/PGS000792.txt.gz |
| PGS012587 (PRS_HNC_OC) |
PGP000822 | Lee YC et al. BMC Med (2024) |
Oral cavity cancer | oral cavity cancer | 972,182 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS012587/ScoringFiles/PGS012587.txt.gz |
| PGS018455 (TPMI_145_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Oral cavity cancer | oral cavity cancer | 1,019 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018455/ScoringFiles/PGS018455.txt.gz | |
| PGS018456 (TPMI_145_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Oral cavity cancer | oral cavity cancer | 939,827 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018456/ScoringFiles/PGS018456.txt.gz | |
| PGS018457 (TPMI_145_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Oral cavity cancer | oral cavity cancer | 17,831 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018457/ScoringFiles/PGS018457.txt.gz | |
| PGS018458 (TPMI_145_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Oral cavity cancer | oral cavity cancer | 983,776 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018458/ScoringFiles/PGS018458.txt.gz | |
| PGS018459 (TPMI_145_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Oral cavity cancer | oral cavity cancer | 1,006,843 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018459/ScoringFiles/PGS018459.txt.gz | |
| PGS018460 (TPMI_145.2_Lassosum2) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 11 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018460/ScoringFiles/PGS018460.txt.gz | |
| PGS018461 (TPMI_145.2_LDpred2) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 34,059 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018461/ScoringFiles/PGS018461.txt.gz | |
| PGS018462 (TPMI_145.2_MegaPRS) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 570,182 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018462/ScoringFiles/PGS018462.txt.gz | |
| PGS018463 (TPMI_145.2_PRS-CS) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 983,776 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018463/ScoringFiles/PGS018463.txt.gz | |
| PGS018464 (TPMI_145.2_SBayesR) |
PGP000835 | Chen HH et al. Nature (2025) |
Tongue cancer | tongue cancer | 1,003,968 | https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS018464/ScoringFiles/PGS018464.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM000201 | PGS000081 (CC_Oral) |
PSS000120| European Ancestry| 411,577 individuals |
PGP000050 | Graff RE et al. Nat Commun (2021) |
Reported Trait: Oral cavity and pharyngeal cancers | OR: 1.08 [1.02, 1.14] | — | — | Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, sex, 10 PCs. | Results from meta-analysis of GERA and UKB |
| PPM002047 | PGS000081 (CC_Oral) |
PSS001020| European Ancestry| 391,479 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |Ext. |
Reported Trait: Incident oral cavity and pharyngeal cancer | HR: 1.11 [1.01, 1.21] | AUROC: 0.702 C-index: 0.686 (0.015) |
— | Age at assessment, sex, genotyping array, PCs(1-15), weekly alcohol intake, cigarettes per day, years of smoking, smoing status (never vs. former vs. current) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM017173 | PGS000081 (CC_Oral) |
PSS010150| European Ancestry| 415 individuals |
PGP000443 | Byrne S et al. Int J Epidemiol (2023) |Ext. |
Reported Trait: Oral cavity and pharyngeal cancers | HR: 1.03 [0.94, 1.14] | — | — | age at baseline, sex (where relevant), assessment centre, 40 principal components of ancestries (PCs), Townsend Index, education, birth location, income, lifestyle index, additional cancer-specific covariates | — |
| PPM001042 | PGS000357 (PRSWEB_PHECODE145_C3-LIP-ORAL-PHARYNX_PT_MGI_20200608) |
PSS000535| European Ancestry| 6,328 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of mouth | OR: 1.111 [1.021, 1.208] β: 0.105 (0.0427) |
AUROC: 0.519 [0.498, 0.542] | Nagelkerke's Pseudo-R²: 0.0021 Brier score: 0.0829 Odds Ratio (OR, top 1% vs. Rest): 1.26 [0.585, 2.73] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE145_C3-LIP-ORAL-PHARYNX_PT_MGI_20200608 |
| PPM001043 | PGS000358 (PRSWEB_PHECODE145_UKBB-SAIGE-HRC-X145_PRS-CS_MGI_20200608) |
PSS000535| European Ancestry| 6,328 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Cancer of mouth | OR: 1.116 [1.024, 1.216] β: 0.11 (0.0438) |
AUROC: 0.528 [0.502, 0.552] | Nagelkerke's Pseudo-R²: 0.00207 Brier score: 0.0829 Odds Ratio (OR, top 1% vs. Rest): 1.63 [0.812, 3.26] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE145_UKBB-SAIGE-HRC-X145_PRS-CS_MGI_20200608 |
| PPM002063 | PGS000792 (CC_Oral_IV) |
PSS001020| European Ancestry| 391,479 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident oral cavity and pharyngeal cancer | HR: 1.12 [1.02, 1.23] | AUROC: 0.702 C-index: 0.687 (0.015) |
R²: 0.356 | Age at assessment, sex, genotyping array, PCs(1-15), weekly alcohol intake, cigarettes per day, years of smoking, smoing status (never vs. former vs. current) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
| PPM030756 | PGS012587 (PRS_HNC_OC) |
PSS012282| European Ancestry| 307,595 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oral cavity cancer | OR: 1.2 [1.1, 1.31] | — | — | age, sex, genotype array, and PC 1 to 10 | — |
| PPM036637 | PGS018455 (TPMI_145_Lassosum2) |
PSS012363| East Asian Ancestry| 19,219 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of mouth | — | AUROC: 0.70787 | R²: 0.03129 | sex, age, array, PCs 1-10 | — |
| PPM036638 | PGS018456 (TPMI_145_LDpred2) |
PSS012362| East Asian Ancestry| 19,219 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of mouth | — | AUROC: 0.71056 | R²: 0.03205 | sex, age, array, PCs 1-10 | — |
| PPM036639 | PGS018457 (TPMI_145_MegaPRS) |
PSS012364| East Asian Ancestry| 19,219 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of mouth | — | AUROC: 0.71117 | R²: 0.03213 | sex, age, array, PCs 1-10 | — |
| PPM036640 | PGS018458 (TPMI_145_PRS-CS) |
PSS012365| East Asian Ancestry| 19,219 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of mouth | — | AUROC: 0.7103 | R²: 0.03215 | sex, age, array, PCs 1-10 | — |
| PPM036641 | PGS018459 (TPMI_145_SBayesR) |
PSS012366| East Asian Ancestry| 19,219 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of mouth | — | AUROC: 0.71212 | R²: 0.03258 | sex, age, array, PCs 1-10 | — |
| PPM036642 | PGS018460 (TPMI_145.2_Lassosum2) |
PSS012358| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68616 | R²: 0.01171 | sex, age, array, PCs 1-10 | — |
| PPM036643 | PGS018461 (TPMI_145.2_LDpred2) |
PSS012357| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68599 | R²: 0.01168 | sex, age, array, PCs 1-10 | — |
| PPM036644 | PGS018462 (TPMI_145.2_MegaPRS) |
PSS012359| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68604 | R²: 0.0117 | sex, age, array, PCs 1-10 | — |
| PPM036645 | PGS018463 (TPMI_145.2_PRS-CS) |
PSS012360| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68622 | R²: 0.0117 | sex, age, array, PCs 1-10 | — |
| PPM036646 | PGS018464 (TPMI_145.2_SBayesR) |
PSS012361| East Asian Ancestry| 19,060 individuals |
PGP000835 | Chen HH et al. Nature (2025) |
Reported Trait: Cancer of tongue | — | AUROC: 0.68563 | R²: 0.01173 | sex, age, array, PCs 1-10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000120 | Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 20010, 20020, 20030, 20040, 20050, 20060, 20070, 20080, 20090, and 20100 | — | [ ,
46.0 % Male samples |
Mean = 58.0 years | European | — | GERA, UKB | — |
| PSS012357 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012358 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012359 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012360 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012361 | 141, V10.01,C01, C02, Z85.810 | — | [ ,
45.19 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS000535 | PheCode:145; ICD9CM:140.0, 140.1, 140.3, 140.4, 140.5, 140.6, 140.8, 140.9, 141.0, 141.1, 141.2, 141.3, 141.4, 141.5, 141.6, 141.8, 141.9, 142.0, 142.1, 142.2, 142.8, 142.9, 143.0, 143.1, 143.8, 143.9, 144.0, 144.1, 144.8, 144.9, 145.0, 145.1, 145.2, 145.3, 145.4, 145.5, 145.6, 145.8, 145.9, 230.0, V10.01; ICD10CM:C00, C00.0, C00.1, C00.2, C00.3, C00.4, C00.5, C00.6, C00.8, C00.9, C01, C02, C02.0, C02.1, C02.2, C02.3, C02.4, C02.8, C02.9, C03, C03.0, C03.1, C03.9, C04, C04.0, C04.1, C04.8, C04.9, C05, C05.0, C05.1, C05.2, C05.8, C05.9, C06, C06.0, C06.1, C06.2, C06.8, C06.80, C06.89, C06.9, C07, C08, C08.0, C08.1, C08.9, D00.0, D00.00, D00.01, D00.02, D00.03, D00.04, D00.05, D00.06, D00.07, D00.08 | — | [
|
— | European | — | MGI | — |
| PSS012363 | 140, 141, 142, 143, 144, 145, 230.0, V10.01,C00, C01, C02, C03, C04, C05, C06, C07, C08, D00.0, Z85.81 | — | [ ,
45.51 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012362 | 140, 141, 142, 143, 144, 145, 230.0, V10.01,C00, C01, C02, C03, C04, C05, C06, C07, C08, D00.0, Z85.81 | — | [ ,
45.51 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012364 | 140, 141, 142, 143, 144, 145, 230.0, V10.01,C00, C01, C02, C03, C04, C05, C06, C07, C08, D00.0, Z85.81 | — | [ ,
45.51 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012282 | — | — | [
|
— | European | — | UKB | — |
| PSS012365 | 140, 141, 142, 143, 144, 145, 230.0, V10.01,C00, C01, C02, C03, C04, C05, C06, C07, C08, D00.0, Z85.81 | — | [ ,
45.51 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS012366 | 140, 141, 142, 143, 144, 145, 230.0, V10.01,C00, C01, C02, C03, C04, C05, C06, C07, C08, D00.0, Z85.81 | — | [ ,
45.51 % Male samples |
— | East Asian (Han Chinese) |
— | TPMI | — |
| PSS010150 | — | — | [
|
— | European | — | UKB | — |
| PSS001020 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [
|
— | European | — | UKB | — |